Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$29.93 - $50.1 $12.8 Million - $21.4 Million
-426,162 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$30.35 - $67.14 $3.02 Million - $6.67 Million
99,384 Added 30.41%
426,162 $17.4 Million
Q4 2019

Feb 14, 2020

SELL
$55.65 - $79.83 $10.2 Million - $14.6 Million
-183,174 Reduced 35.92%
326,778 $20.2 Million
Q3 2019

Nov 14, 2019

SELL
$64.7 - $85.39 $2.55 Million - $3.37 Million
-39,449 Reduced 7.18%
509,952 $37.2 Million
Q4 2018

Feb 14, 2019

BUY
$41.17 - $56.44 $1.52 Million - $2.09 Million
37,000 Added 7.22%
549,401 $24.7 Million
Q3 2018

Nov 14, 2018

BUY
$52.95 - $71.34 $6.11 Million - $8.24 Million
115,478 Added 29.09%
512,401 $29 Million
Q2 2018

Aug 14, 2018

BUY
$56.38 - $68.08 $1.16 Million - $1.4 Million
20,609 Added 5.48%
396,923 $26.5 Million
Q3 2017

Nov 14, 2017

BUY
$43.46 - $52.49 $16.4 Million - $19.8 Million
376,314
376,314 $19.8 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.08B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Mangrove Partners Portfolio

Follow Mangrove Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

News

Stay updated on Mangrove Partners with notifications on news.